These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16835140)
1. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome. Flierl MA; Schreiber H; Huber-Lang MS J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140 [TBL] [Abstract][Full Text] [Related]
2. A key role of C5a/C5aR activation for the development of sepsis. Riedemann NC; Guo RF; Ward PA J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283 [TBL] [Abstract][Full Text] [Related]
3. Role of C5 activation products in sepsis. Ward PA ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490 [TBL] [Abstract][Full Text] [Related]
4. The dark side of C5a in sepsis. Ward PA Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586 [TBL] [Abstract][Full Text] [Related]
5. C5a anaphylatoxin and its role in critical illness-induced organ dysfunction. Wood AJT; Vassallo A; Summers C; Chilvers ER; Conway-Morris A Eur J Clin Invest; 2018 Dec; 48(12):e13028. PubMed ID: 30229880 [TBL] [Abstract][Full Text] [Related]
6. [Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis]. Fang Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):155-7. PubMed ID: 25665619 [No Abstract] [Full Text] [Related]
7. Role of C5a in multiorgan failure during sepsis. Huber-Lang M; Sarma VJ; Lu KT; McGuire SR; Padgaonkar VA; Guo RF; Younkin EM; Kunkel RG; Ding J; Erickson R; Curnutte JT; Ward PA J Immunol; 2001 Jan; 166(2):1193-9. PubMed ID: 11145701 [TBL] [Abstract][Full Text] [Related]
8. The harmful role of c5a on innate immunity in sepsis. Ward PA J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003 [TBL] [Abstract][Full Text] [Related]
9. Complement as a Major Inducer of Harmful Events in Infectious Sepsis. Fattahi F; Zetoune FS; Ward PA Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106 [TBL] [Abstract][Full Text] [Related]
11. Complement C5a Receptor 1 Exacerbates the Pathophysiology of Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO mBio; 2018 Jan; 9(1):. PubMed ID: 29362231 [TBL] [Abstract][Full Text] [Related]
12. Role of C5a in inflammatory responses. Guo RF; Ward PA Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587 [TBL] [Abstract][Full Text] [Related]
13. The role of the complement system and the activation fragment C5a in the central nervous system. Woodruff TM; Ager RR; Tenner AJ; Noakes PG; Taylor SM Neuromolecular Med; 2010 Jun; 12(2):179-92. PubMed ID: 19763906 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a functional role of the second C5a receptor C5L2. Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721 [TBL] [Abstract][Full Text] [Related]
15. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction. Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445 [TBL] [Abstract][Full Text] [Related]
16. Role of complement in multiorgan failure. Rittirsch D; Redl H; Huber-Lang M Clin Dev Immunol; 2012; 2012():962927. PubMed ID: 23320021 [TBL] [Abstract][Full Text] [Related]
17. Sepsis, apoptosis and complement. Ward PA Biochem Pharmacol; 2008 Dec; 76(11):1383-8. PubMed ID: 18848819 [TBL] [Abstract][Full Text] [Related]
18. Role of C5a-C5aR axis in the development of atherosclerosis. An G; Ren G; An F; Zhang C Sci China Life Sci; 2014 Aug; 57(8):790-4. PubMed ID: 25104451 [TBL] [Abstract][Full Text] [Related]
19. Role of C5a-C5aR interaction in sepsis. Guo RF; Riedemann NC; Ward PA Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676 [TBL] [Abstract][Full Text] [Related]
20. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects. Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]